OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Signaling Pathways and Natural Compounds in Triple-Negative Breast Cancer Cell Line
Citra Dewi, Adryan Fristiohady, Riezki Amalia, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3661-3661
Open Access | Times Cited: 23
Citra Dewi, Adryan Fristiohady, Riezki Amalia, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3661-3661
Open Access | Times Cited: 23
Showing 23 citing articles:
Natural Compounds, Optimal Combination of Brusatol and Polydatin Promote Anti-Tumor Effect in Breast Cancer by Targeting Nrf2 Signaling Pathway
Jing Li, Jianchao Zhang, Yan Zhu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8265-8265
Open Access | Times Cited: 17
Jing Li, Jianchao Zhang, Yan Zhu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8265-8265
Open Access | Times Cited: 17
Phyto-therapeutics as anti-cancer agents in breast cancer: Pathway targeting and mechanistic elucidation
Abdullah Almilaibary
Saudi Journal of Biological Sciences (2024) Vol. 31, Iss. 3, pp. 103935-103935
Open Access | Times Cited: 5
Abdullah Almilaibary
Saudi Journal of Biological Sciences (2024) Vol. 31, Iss. 3, pp. 103935-103935
Open Access | Times Cited: 5
In Vitro Cytotoxicity Assessment of Betulinic Acid Organic Salts on Triple-Negative Breast Cancer Cells
Sonia Apostolova, Irina Georgieva, Paula Ossowicz‐Rupniewska, et al.
Sci (2025) Vol. 7, Iss. 1, pp. 2-2
Open Access
Sonia Apostolova, Irina Georgieva, Paula Ossowicz‐Rupniewska, et al.
Sci (2025) Vol. 7, Iss. 1, pp. 2-2
Open Access
Comprehensive pharmacokinetic profiling and molecular docking analysis of natural bioactive compounds targeting oncogenic biomarkers in breast cancer
Basim Othman, Saba Beigh, Mohammad Albanghali, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Basim Othman, Saba Beigh, Mohammad Albanghali, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Phytometabolites as modulators of breast cancer: a comprehensive review of mechanistic insights
Priyanka Sharma, Khushi Gupta, Sumit Kumar Khandai, et al.
Medical Oncology (2024) Vol. 41, Iss. 2
Closed Access | Times Cited: 4
Priyanka Sharma, Khushi Gupta, Sumit Kumar Khandai, et al.
Medical Oncology (2024) Vol. 41, Iss. 2
Closed Access | Times Cited: 4
Echinacoside regulates PI3K/AKT/HIF-1α/VEGF cross signaling axis in proliferation and apoptosis of breast cancer
Hongyi Liang, Guoliang Yin, Guangxi Shi, et al.
Analytical Biochemistry (2023) Vol. 684, pp. 115360-115360
Closed Access | Times Cited: 9
Hongyi Liang, Guoliang Yin, Guangxi Shi, et al.
Analytical Biochemistry (2023) Vol. 684, pp. 115360-115360
Closed Access | Times Cited: 9
Triple Negative Breast Cancer (TNBC): Signalling pathways-Role of plant-based inhibitors
Ravindra B. Malabadi, Sadiya MR, Kiran P. Kolkar, et al.
Open Access Research Journal of Biology and Pharmacy (2024) Vol. 10, Iss. 2, pp. 028-071
Open Access | Times Cited: 2
Ravindra B. Malabadi, Sadiya MR, Kiran P. Kolkar, et al.
Open Access Research Journal of Biology and Pharmacy (2024) Vol. 10, Iss. 2, pp. 028-071
Open Access | Times Cited: 2
Functionalized solid lipid nanoparticles combining docetaxel and erlotinib synergize the anticancer efficacy against triple-negative breast cancer
Aiswarya Chaudhuri, Dulla Naveen Kumar, Dinesh Kumar, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 201, pp. 114386-114386
Closed Access | Times Cited: 2
Aiswarya Chaudhuri, Dulla Naveen Kumar, Dinesh Kumar, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 201, pp. 114386-114386
Closed Access | Times Cited: 2
Deciphering the landscape of triple negative breast cancer from microenvironment dynamics and molecular insights to biomarker analysis and therapeutic modalities
Harshita Tiwari, Swati Singh, Sonal Sharma, et al.
Medicinal Research Reviews (2024)
Closed Access | Times Cited: 2
Harshita Tiwari, Swati Singh, Sonal Sharma, et al.
Medicinal Research Reviews (2024)
Closed Access | Times Cited: 2
Therapeutic potential of flavonoids from traditional Chinese medicine in pancreatic cancer treatment
Qi Wan, Qing Ren, Shuangying Qiao, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 2
Qi Wan, Qing Ren, Shuangying Qiao, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 2
Insights into the potential of Sanguinarine as a promising therapeutic option for breast cancer
Rama Rao Malla, Priyamvada Bhamidipati, Meghapriya Adem
Biochemical Pharmacology (2023) Vol. 212, pp. 115565-115565
Closed Access | Times Cited: 7
Rama Rao Malla, Priyamvada Bhamidipati, Meghapriya Adem
Biochemical Pharmacology (2023) Vol. 212, pp. 115565-115565
Closed Access | Times Cited: 7
Validation of Dual-Action Chemo-Radio-Labeled Nanocarriers with High Efficacy against Triple-Negative Breast Cancer
Shaista Ilyas, Sabri E. M. Sahnoun, Annika Szymura, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 42, pp. 48963-48977
Closed Access | Times Cited: 5
Shaista Ilyas, Sabri E. M. Sahnoun, Annika Szymura, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 42, pp. 48963-48977
Closed Access | Times Cited: 5
Tailoring Potential Natural Compounds for the Treatment of Luminal Breast Cancer
Fernanda Cardoso da Silva, Douglas Cardoso Brandão, Everton Allan Ferreira, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1466-1466
Open Access | Times Cited: 5
Fernanda Cardoso da Silva, Douglas Cardoso Brandão, Everton Allan Ferreira, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1466-1466
Open Access | Times Cited: 5
The Anticancer Effects of Marine Carotenoid Fucoxanthin through Phosphatidylinositol 3-Kinase (PI3K)-AKT Signaling on Triple-Negative Breast Cancer Cells
Shade’ A. Ahmed, Patricia Mendonca, Samia S. Messeha, et al.
Molecules (2023) Vol. 29, Iss. 1, pp. 61-61
Open Access | Times Cited: 5
Shade’ A. Ahmed, Patricia Mendonca, Samia S. Messeha, et al.
Molecules (2023) Vol. 29, Iss. 1, pp. 61-61
Open Access | Times Cited: 5
Potential of injectable psoralen polymeric lipid nanoparticles for cancer therapeutics
Fengjie Liu, Yuanyuan Huang, Xiujuan Lin, et al.
Arabian Journal of Chemistry (2024) Vol. 17, Iss. 10, pp. 105947-105947
Open Access | Times Cited: 1
Fengjie Liu, Yuanyuan Huang, Xiujuan Lin, et al.
Arabian Journal of Chemistry (2024) Vol. 17, Iss. 10, pp. 105947-105947
Open Access | Times Cited: 1
Accessing Apoptosis Induction and Metastasis Inhibition Effect of Magnolol on Triple Negative Breast CancerIn Vitro
Yu-Ching Li, Chui-Na Wong, Fei‐Ting Hsu, et al.
In Vivo (2023) Vol. 37, Iss. 3, pp. 1028-1036
Open Access | Times Cited: 4
Yu-Ching Li, Chui-Na Wong, Fei‐Ting Hsu, et al.
In Vivo (2023) Vol. 37, Iss. 3, pp. 1028-1036
Open Access | Times Cited: 4
Administration of Inhibitory Molecules through Nanoparticles in Breast Cancer Therapy
Christian Rafael Quijia, Andreina Quevedo Enríquez, Carlos Daniel Zappia, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 6, pp. 726-761
Closed Access | Times Cited: 2
Christian Rafael Quijia, Andreina Quevedo Enríquez, Carlos Daniel Zappia, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 6, pp. 726-761
Closed Access | Times Cited: 2
Transformative Insights
Rita Komalasari
Advances in bioinformatics and biomedical engineering book series (2024), pp. 184-207
Closed Access
Rita Komalasari
Advances in bioinformatics and biomedical engineering book series (2024), pp. 184-207
Closed Access
Selective Cytotoxicity of Anthocyanins on Breast Cancer Cells
Mary Krystelle Catacutan, Tae‐Yeon Kim, Sungmun Lee
Research Square (Research Square) (2024)
Open Access
Mary Krystelle Catacutan, Tae‐Yeon Kim, Sungmun Lee
Research Square (Research Square) (2024)
Open Access
Slow Sulfide Donor GYY4137 Increased the Sensitivity of Two Breast Cancer Cell Lines to Paclitaxel by Different Mechanisms
Veronika Lišková, Barbora Chovancova, Kristina Galvankova, et al.
Biomolecules (2024) Vol. 14, Iss. 6, pp. 651-651
Open Access
Veronika Lišková, Barbora Chovancova, Kristina Galvankova, et al.
Biomolecules (2024) Vol. 14, Iss. 6, pp. 651-651
Open Access
The vitamin D analog EB1089 sensitizes triple-negative breast cancer cells to the antiproliferative effects of antiestrogens
Adriana Zárate-Pérez, Alitzin Pamela Cruz-Cázares, David Ordaz‐Rosado, et al.
Advances in Medical Sciences (2024) Vol. 69, Iss. 2, pp. 398-406
Closed Access
Adriana Zárate-Pérez, Alitzin Pamela Cruz-Cázares, David Ordaz‐Rosado, et al.
Advances in Medical Sciences (2024) Vol. 69, Iss. 2, pp. 398-406
Closed Access
Uncovering novel pathogenic variants and pathway mutations in triple-negative breast cancer among the endogamous mizo tribe
Lalawmpuii Pachuau, H. Lalremmawia, Lalengkimi Ralte, et al.
Breast Cancer Research and Treatment (2024)
Closed Access
Lalawmpuii Pachuau, H. Lalremmawia, Lalengkimi Ralte, et al.
Breast Cancer Research and Treatment (2024)
Closed Access
Advances in Epigenetic Therapeutics for Breast Cancer
Michel-Gael F. Guefack, Sanchita Bhatnagar
Advances in experimental medicine and biology (2024), pp. 89-97
Closed Access
Michel-Gael F. Guefack, Sanchita Bhatnagar
Advances in experimental medicine and biology (2024), pp. 89-97
Closed Access
